FDA Inspection 1023704 — Biomat USA Inc

Biomat USA Inc — FEI 3005523333

The FDA completed an inspection of Biomat USA Inc on August 31, 2017 in Richmond, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 31, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Richmond, VA (United States)

Citations

IDCFRDescription
442521 CFR 606.60(a)Equipment observed, standardized, calibrated